Inhibiting VEGF pathway could lead to reduced colorectal cancer angiogenesis, and decreased colorectal cancer proliferation, migration (Xu et al., 2018), indicating that MIR4435-2HG might promote colorectal cancer cell growth, metastasis, and poor survival via P38/MAPK and VEGF pathway. This evidence concerns the gene VEGFA and colorectal cancer.